$17M for Stent Maker TriReme

10/12/10

TriReme Medical, a Pleasanton, CA-based developer of cardiovascular stents, catheters, and balloons, said this week that it has raised $17 million in Series D funding. The round was led by EDB Investments subsidiary Bio*One Capital of Singapore, with existing investors Three Arch Partners and Adams Street Partners also participating. “This investment will allow us to ramp up our commercial activities worldwide, continue to develop internal R&D programs and pursue key regulatory approvals for our products in large markets such as the US, Japan, and China,” said TriReme president and CEO Eitan Konstantino in a statement.

Wade Roush is Chief Correspondent and Editor At Large at Xconomy. You can subscribe to his Google Group or e-mail him at wroush@xconomy.com. Follow @

By posting a comment, you agree to our terms and conditions.